ArticlePharmacology research & perspectives2023

Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non-alcoholic steatohepatitis (NASH).

Natsuko Hada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.